| Kelly Rabah, LISW-S, CPHQ, CPHRM | |
|
151 Woodside Park Dr, Amelia, OH 45102-8711 | |
| (513) 882-2335 | |
| Not Available |
| Full Name | Kelly Rabah |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 151 Woodside Park Dr, Amelia, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346863602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | I.0010244 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Rabah, LISW-S, CPHQ, CPHRM 20 S 3rd St Ste 210, Columbus, OH 43215-4206 Ph: (833) 205-2030 | Kelly Rabah, LISW-S, CPHQ, CPHRM 151 Woodside Park Dr, Amelia, OH 45102-8711 Ph: (513) 882-2335 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
ZOLL Medical Corporation announced today that in a "Best of the Best" presentation at the American Heart Association Resuscitation Science Symposium in Orlando Florida, Daniel P. Davis, M.D., presented research from the University of California Resuscitation Research Center that shows a major improvement in patient outcome after cardiac arrest.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the commencement of an oral drug delivery Feasibility and Option agreement with one of the world's top ten biggest pharmaceutical companies. The agreement will evaluate the ability of Merrion's patented GIPET technology to boost the bioavailablity of three of the 'big pharma' company's compounds.
Scientists have designed a novel method for improving the delivery of therapeutic molecules into diseased cells such as those found in cancer and tuberculosis.
› Verified 4 days ago
David B Callan, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 43 E Main St, Amelia, OH 45102 Phone: 513-947-7000 Fax: 513-947-7222 | |
Michelle M Whitford, LISW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 43 E Main St, Amelia, OH 45102 Phone: 513-947-7000 Fax: 513-947-7050 | |
Ms. Marae Martin, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 37 E Main St, Amelia, OH 45102 Phone: 513-753-9964 Fax: 513-753-9968 | |
Ms. Jane Kaitz Cohen, MSW,LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 43 E Main St, Amelia, OH 45102 Phone: 513-345-8555 | |
Brent Hartke, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 43 E Main St, Amelia, OH 45102 Phone: 513-947-7000 | |
Cynthia S Crew, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 43 E Main St, Amelia, OH 45102 Phone: 513-947-7030 Fax: 513-947-7001 |